Xushan Yang

502 total citations
9 papers, 324 citations indexed

About

Xushan Yang is a scholar working on Epidemiology, Biomaterials and Surgery. According to data from OpenAlex, Xushan Yang has authored 9 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Biomaterials and 2 papers in Surgery. Recurrent topics in Xushan Yang's work include Electrospun Nanofibers in Biomedical Applications (3 papers), Hydrogels: synthesis, properties, applications (2 papers) and Autophagy in Disease and Therapy (2 papers). Xushan Yang is often cited by papers focused on Electrospun Nanofibers in Biomedical Applications (3 papers), Hydrogels: synthesis, properties, applications (2 papers) and Autophagy in Disease and Therapy (2 papers). Xushan Yang collaborates with scholars based in China and Germany. Xushan Yang's co-authors include Wenzhen Liao, Yudi Deng, Xu Dong Zhang, Miaomiao Yuan, Lianzhi Mao, Lixia Liu, Meiling He, Mengnan Wang, Ye Tian and Xuemei Chen and has published in prestigious journals such as Journal of Hazardous Materials, Oncogene and International Journal of Biological Macromolecules.

In The Last Decade

Xushan Yang

9 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xushan Yang China 7 101 97 54 51 46 9 324
Guangming Wan China 9 100 1.0× 87 0.9× 43 0.8× 52 1.0× 24 0.5× 27 383
Zhirui Zhang China 11 53 0.5× 138 1.4× 57 1.1× 58 1.1× 21 0.5× 28 342
Farideh Mohammadian Iran 11 133 1.3× 184 1.9× 71 1.3× 85 1.7× 49 1.1× 17 464
Mehrafarin Fesharaki Iran 11 159 1.6× 111 1.1× 112 2.1× 25 0.5× 24 0.5× 30 472
Xiaoyi Zheng China 11 114 1.1× 76 0.8× 95 1.8× 19 0.4× 60 1.3× 23 368
Yingxi Li China 12 63 0.6× 89 0.9× 25 0.5× 34 0.7× 19 0.4× 44 376
Parviz Vahedi Iran 8 90 0.9× 125 1.3× 84 1.6× 53 1.0× 16 0.3× 13 384
Iris E. Allijn Netherlands 11 76 0.8× 109 1.1× 124 2.3× 18 0.4× 35 0.8× 13 386

Countries citing papers authored by Xushan Yang

Since Specialization
Citations

This map shows the geographic impact of Xushan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xushan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xushan Yang more than expected).

Fields of papers citing papers by Xushan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xushan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xushan Yang. The network helps show where Xushan Yang may publish in the future.

Co-authorship network of co-authors of Xushan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xushan Yang. A scholar is included among the top collaborators of Xushan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xushan Yang. Xushan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Yang, Xushan, et al.. (2023). A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternation. The Journal of Nutritional Biochemistry. 118. 109353–109353. 10 indexed citations
2.
Deng, Yudi, et al.. (2022). Anti-atherosclerosis effect of nobiletin via PINK1/Parkin-mediated mitophagy and NLRP3 inflammasome signaling pathway. Journal of Functional Foods. 100. 105369–105369. 6 indexed citations
3.
Yang, Xushan, et al.. (2022). Nobiletin mitigates NAFLD via lipophagy and inflammation. Food & Function. 13(19). 10186–10199. 20 indexed citations
4.
Deng, Yudi, Xu Dong Zhang, Xushan Yang, et al.. (2020). Subacute toxicity of mesoporous silica nanoparticles to the intestinal tract and the underlying mechanism. Journal of Hazardous Materials. 409. 124502–124502. 55 indexed citations
5.
Deng, Yudi, Xushan Yang, Xu Dong Zhang, et al.. (2020). Novel fenugreek gum-cellulose composite hydrogel with wound healing synergism: Facile preparation, characterization and wound healing activity evaluation. International Journal of Biological Macromolecules. 160. 1242–1251. 54 indexed citations
6.
Yang, Xushan, Hong Deng, Yuting Hao, et al.. (2020). Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases. Frontiers in Bioengineering and Biotechnology. 8. 251–251. 47 indexed citations
7.
Deng, Yudi, Jinyuan Chen, Jinyu Huang, et al.. (2020). Preparation and characterization of cellulose/flaxseed gum composite hydrogel and its hemostatic and wound healing functions evaluation. Cellulose. 27(7). 3971–3988. 41 indexed citations
8.
Shi, Linna, et al.. (2019). [Role of lipophagy in the regulation of lipid metabolism and the molecular mechanism].. PubMed. 39(7). 867–874. 6 indexed citations
9.
Wen, Ying, Xueqiong Zhou, Meiling He, et al.. (2018). Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma. Oncogene. 38(11). 1845–1859. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026